Log in

upcoming Events & webinars


    • 10 Jul 2018
    • 10:00 AM (EDT)
    • 10 Jul 2022
    • 11:00 AM (EDT)
    • Webinar

    Identifying and Treating Monogenic Diabetes

    Presented by
    Maggie Shepherd, RGN, PhD

    This webinar will provide an update on monogenic diabetes, highlighting how to identify possible cases and the impact of a genetic diagnosis. Genes causing both maturity onset diabetes of the young (MODY) and neonatal diabetes will be discussed. Simple and inexpensive steps which can be taken to aid differential diagnosis will be described. Case studies will be used to highlight the specific characteristics associated with different types of monogenic diabetes, ensuring the appropriate tests are recommended, enabling accurate diagnosis and most appropriate treatment. Ensuing treatment changes, implications for other family members and the emotional impact of a ‘new genetic diagnosis’ and the consequence of stopping insulin injections, even after many years on this treatment, will be discussed.

    Who Should Attend?
    This webinar will be of interest to all healthcare professionals involved in diabetes care. No previous experience of monogenic diabetes will be required. Any healthcare professionals looking to ensure their patients have the correct diagnosis and treatment and interested in increasing their awareness of monogenic diabetes should attend.

    During this presentation attendees will learn:

    • How to identify individuals likely to have monogenic diabetes
    • Aids to differential diagnosis (for example use of MODY probability calculator, c-peptide and antibodies)
    • Where to access more information on monogenic diabetes

    Maggie Shepherd, RGN, PhD
    Honorary Clinical Professor
    University of Exeter Medical School
    Medical Research
    Exeter, United Kingdom 

    Maggie trained as an RGN at King’s College Hospital and worked as Diabetes Specialist Nurse in Greenwich prior to joining the monogenic diabetes team in Exeter in 1995.  She has a PhD in Medical Science and qualifications in Medical Education, Genetic Counselling and Genomic Medicine. Also, she is the Honorary Clinical Professor at the University of Exeter Medical School, Lead Nurse for Research at the Royal Devon and Exeter NHS Foundation Trust and lead co-ordinator of the national, award winning Genetic Diabetes Nurse project.

    Particular interests include increasing awareness of monogenic diabetes, ensuring correct diagnosis and treatment.  Maggie has over 100 publications (30 first author) and is an Editorial Board member of the European Diabetes Nursing Journal.

    Maggie delivered the Janet Kinson award lecture at DUK in 2003, is a member of the team receiving the Queens Anniversary Prize for Higher and Further Education in 2006, Hospital Doctor Academic Medicine Team of the Year 2005 and BMJ diabetes team of the year 2016. 

    $10.00 for ISONG Members and Students
    $15.00 for Non-Members

    Contact Hours

    ISONG and ANA-NY are collaborating to provide this learning activity. Nurse participants completing the activity and the evaluation tool will receive one (1) continuing nursing education contact hour. The Northeast Multi-State Division is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

    • 07 Nov 2018
    • 12:00 PM (EST)
    • 05 Nov 2021
    • 1:00 PM (EDT)
    • webinar

    Direct to Consumer Genetic Testing Webinar

    Presented by
    Nicole Osier, PhD, RN

    The purpose of this webinar is to provide the learner with fundamental information regarding the rapidly growing field of direct to consumer testing. The goal is to provide learners with a strong foundation as well as resources to find additional reputable information. Topics for discussion include: (1) what direct to consumer genetic testing is and why it has become so popular; (2) applications of direct to consumer testing and the type of information they can provide; (3) how the testing works; (4) the strengths and limitations of direct-to-consumer testing; (5) factors that can impact results; (6) implications of direct-to-consumer testing on health care. Case studies from several clinical settings will be provided.

    Who Should Attend?
    Clinicians who have patients who have or may come to them with direct to consumer genetic testing results

    • Anyone who has pursued or is considering direct to consumer genetic testing
    • Anyone who is interested in genetic testing for ancestry

     - After this presentation attendees will know/learn:

    • Interpret direct to consumer genetic testing results in light of relevant personal and
       lifestyle characteristics.
    • Understand the strengths and limitations of direct to consumer ancestry tests.
    • Evaluate the real or potential ethical, legal, social, and financial implications of direct to consumer testing.

    Dr. Osier is an Assistant Professor and new addition to the University of Texas at Austin faculty. She holds joint appointments in the School of Nursing (Division of Holistic Adult Health) and Dell Medical School (Department of Neurology). Dr. Osier also serves as the Director of the Biobehavioral Core of St. David’s Center for Health Promotion and Disease Prevention Research in Underserved Populations (CHPR). Dr. Osier’s training background includes dual bachelor’s degrees from Michigan State University (in Nutritional Science and Nursing), a PhD from the University of Pittsburgh (in Nursing with an emphasis on Molecular Genomics), and a post-doctoral fellowship at the National Institutes of Health (in Nursing with an emphasis on Protein Quantification).

    To-date, Dr. Osier’s program of research has centered on using both pre-clinical and clinical research to promote understanding the molecular and genomic underpinnings of health, disease, and injury recovery. Her current research focuses on understanding the pathology associated with traumatic brain injury (TBI). Her ultimate goal is to harness this information to predict individuals at highest risk for poor outcomes and ultimately to inform precision care initiatives. Dr. Osier teaches Genetics in Health Care to undergraduate students, where she strives to incorporate innovative experiential learning methods.

    CE Credits
    ISONG and ANA-NY are collaborating to provide this learning activity.  Nurse participants completing the activity and the evaluation tool will receive one (1) continuing nursing education contact hour.  The Northeast Multi-State Division is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

    $10.00 for ISONG Members
    $10.00 for ANA NY Members with code
    $15. 00 for Students
    $15.00 for Non-Members

    Thank you to our sponsor: 

    23andMe resources for clinicians:

    ·  23andMe’s website for clinicians: view sample genetic reports, webinars and FAQs

    · 23andMe’s Ancestry Composition report

    For questions, contact medical@23andMe.com

    • 01 Jun 2020
    • (EDT)
    • 01 Jun 2023
    • (EDT)
    • at your convenience

    Presented by
    Dennis J. Cheek, RN, PhD, FAHA


    Genomics is a central science for all advanced practice nurses due to the fact that many diseases and conditions have a genetic or genomic component. In the imminent future, all health care will increasingly include genetic and genomic information including pathways of prevention, screening, diagnostics, pharmacology, selection of treatment, and monitoring of treatment effectiveness. This webinar will examine the advances in pharmacogenomics, which is the study of genetic/genomic variation and how these variation influence drug therapy.

    Target Audience
    Personalized medicine has arrived and this webinar is designed to provide the clinical nurse with the latest information on pharmacogenomics in their clinical practice. The webinar will also provide the advanced practice additional information on additional pharmacogenomics information for prescribing and monitoring of drug therapy.


    1. Explain the difference between genetics and genomics.
    2. Discuss the clinical importance of pharmacogenomics in the clinical setting.
    3. Discuss the role of the healthcare provider with regard to pharmacogenomics data and patient management. 

    Dennis J. Cheek, RN, PhD, FAHA is currently the Abell-Hanger Professor in Gerontological Nursing at Texas Christian University - Harris College of Nursing and Health Sciences with a joint appointment in the School of Nurse Anesthesia.

    He received his Bachelor of Science in Nursing from California State University, Fresno and his Masters of Science in Nursing from the University of California, San Francisco with a focus in Critical Care Nursing and Education. 

    He received his Doctor of Philosophy in Cellular & Molecular Pharmacology and Physiology from the University of Nevada, Reno and was awarded a Nevada AHA Affiliate Post - Doctoral Fellowship to continue his research. His teaching responsibilities include undergraduate pharmacology, graduate pathophysiology and pharmacology, nurse anesthesia pharmacology and cardiovascular physiology as well as one the core courses' in the Doctoral of Nursing Practice program at TCU. 

    Along with his teaching responsibilities, he is continuing his program of research in the newly renovated Nursing Research Laboratory studying the effects of age on endothelial cells. Dennis has been a member of the Council on Cardiovascular Nursing since 2000 and was inducted as a Fellow of the American Heart Association (FAHA). He has published in numerous journals including American Journal of Critical Care, American Association of Critical Care Nurses Clinical Issues, American Association of Nurse Anesthetist , American Journal of Physiology: Heart and Circulatory, Biological Research in Nursing, Circulation Research, Critical Care Nurse, Heart & Lung, Journal of Emergency Nursing, Journal of Nursing Scholarship, Proceedings of the National Academy of Sciences in the United States and The Journal of Cardiovascular Nursing.

    Continuing Educational Credits 
    This learning activity has been developed in collaboration with the University of Pittsburgh School of Nursing.

    Participants successfully completing this activity will be awarded one (1) nursing professional development pharmacotherapeutic contact hour.

    The University of Pittsburgh School of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    • 05 Nov 2021
    • 9:00 AM (EDT)
    • 07 Nov 2021
    • 12:00 PM (EST)
    • Virtual via Airmeet

    Promoting Diversity, Inclusion, and Health Equity
    in Genomic Nursing

    On behalf of the 2021 ISONG Congress Planning Committee, we invite you to join us at the virtual 2021 Congress: “Promoting Diversity, Inclusion, and Health Equity in Genomic Nursing.”  While the pandemic continues to affect our plans to be together in person this November, we are fortunate to have had a positive experience last year using the Airmeet platform to connect virtually with genetic/genomic nursing colleagues around the world. 

    The 2021 ISONG Congress will provide the attendee the opportunity to:.
    • Understand how health and quality of life outcomes are impacted by genomic diversity and social determinants of health.
    • Identify the unique contributions of nursing in promoting diversity, inclusion, and health equity in omic nursing practice, education and/or research.
    • Incorporate the concepts of diversity, inclusion, and health equity into one’s routine nursing omic practice, education, and/or research. 

    Click here for additional Congress details.

    Pre-Congress registration will open in May.

    The International Society of Nurses in Genetics and the University of Pittsburgh School of Nursing are collaborating to present the 2021 ISONG Virtual World Congress.  Professional Nurses participating in the congress and completing the evaluation tool will receive nursing continuing professional development contact hours.  The University of Pittsburgh School of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

    Contact Amy Spikula at amy@isong.org if you have any questions.

© International Society  ofNurses in Genetics (ISONG)
ISONG Privacy Policy
Powered by Wild Apricot Membership Software